Psychopharmacology of Pediatric Bipolar Disorders in Children and Adolescents

Tiffany Thomas, Libbie Stansifer, Robert L. Findling

Research output: Contribution to journalReview articlepeer-review

Abstract

Pediatric bipolar disorder (PBD) is a chronic and disabling illness often leading to serious disruption in the lives of children and adolescents with this condition. Until recently, methodologically stringent data to guide pharmacologic interventions in the youth were scarce. However, clinical trials conducted recently have expanded the existing evidence base, and new data are emerging rapidly. Recent studies have examined the use of lithium, anticonvulsants, and atypical antipsychotics for acute and long-term treatment of PBD. Despite these new advances, further placebo-controlled trials investigating the efficacy and safety of pharmacologic treatment strategies for young people with bipolar disorder are still needed.

Original languageEnglish (US)
Pages (from-to)173-187
Number of pages15
JournalPediatric clinics of North America
Volume58
Issue number1
DOIs
StatePublished - Feb 2011
Externally publishedYes

Keywords

  • Anticonvulsants
  • Atypical antipsychotics
  • Lithium
  • Pediatric bipolar disorder
  • Pharmacotherapy
  • Treatment

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint

Dive into the research topics of 'Psychopharmacology of Pediatric Bipolar Disorders in Children and Adolescents'. Together they form a unique fingerprint.

Cite this